Related references
Note: Only part of the references are listed.Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis
Giacomo Tini et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure
Emil Wolsk et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Heart Failure Stimulates Tumor Growth by Circulating Factors
Wouter C. Meijers et al.
CIRCULATION (2018)
Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study
Annamaria Iorio et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
Nathalie Conrad et al.
LANCET (2018)
Comorbidity health pathways in heart failure patients: A sequences-of-regressions analysis using cross-sectional data from 10,575 patients in the Swedish Heart Failure Registry
Claire A. Lawson et al.
PLOS MEDICINE (2018)
Linking Heart Failure to Cancer: Background Evidence and Research Perspectives
Edoardo Bertero et al.
CIRCULATION (2018)
Basic characteristics and representativeness of the German Disease Analyzer database
Wolfgang Rathmann et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2018)
QRS duration is associated with outcome in symptomatic HF patients. What about ACCF/AHA stages A and B? Data from the DAVID-Berg study
A. Andrea Pozzi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Incidence of cancer in patients with chronic heart failure: a long-term follow-up study
Ann Banke et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer
Tal Hasin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality
Noemi Pavo et al.
HEART (2015)
Affixin (β-parvin) promotes cardioprotective signaling via STAT3 activation
Mark Luedde et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Share Paper
